← Back to Search

Behavioral Intervention

Digital Health Solution for ADHD Treatment Adherence (dHealth Trial)

N/A
Waitlist Available
Led By Linda Pfiffner, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Child aged 6-11 (grades 1-5)
Child aged 7-11 (grades 2-5)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline on child impairments at 2 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will develop a new digital health solution to help parents better adhere to evidence-based parenting strategies.

Who is the study for?
This trial is for children aged 6-11 with significant ADHD symptoms, attending a participating SFUSD elementary school in a mainstream classroom. They must have challenges with attention or hyperactivity/impulsivity identified by school mental health professionals and live with a caretaker who can participate in treatment. Children cannot join if they have severe sensory impairments, language delays, psychosis, pervasive developmental disorders, or intellectual impairments.
What is being tested?
The study tests a digital health solution aimed at helping parents adhere to behavioral treatments for their child's ADHD. It involves using the 'CaregiverAssist' program alongside traditional Behavioral Parent Training (CLS Parent Group) to see if it improves the use of parenting strategies.
What are the potential side effects?
Since this trial focuses on behavioral training and digital solutions rather than medication, there are no direct medical side effects expected. However, participants may experience stress or frustration related to technology use or changes in routine.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My child is between 6 and 11 years old and in grades 1-5.
Select...
My child is between 7 and 11 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline on adhd and oppositional behaviors at 2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline on adhd and oppositional behaviors at 2 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Feasibility Rating Scale
Parent Acceptability and Satisfaction Questionnaire
Parent adherence/implementation
+1 more
Secondary study objectives
Alabama Parenting Questionnaire
Barkley Deficit in Executive Functions Scale
Child and Adolescent Symptom Inventory (CASI-V)
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: dHealth tool and BPT GroupExperimental Treatment2 Interventions
Parents and School Mental Health Providers (SMHPs) will participate in a 2-month trial during which they will use a digital Health (dHealth) tool in daily life contexts while receiving BPT, aimed to improve parent adherence sustained use of evidence-based parenting strategies. They will also participate in focus groups and discussions to facilitate the build, design, and use of the dHealth.
Group II: BPT GroupExperimental Treatment1 Intervention
Parents and School Mental Health Providers (SMHPs) will participate in a 2-month trial during which they will be receiving BPT without the use of a digital Health (dHealth) tool.

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,591 Previous Clinical Trials
14,901,523 Total Patients Enrolled
8 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
1,770 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
Linda Pfiffner, PhDPrincipal InvestigatorUniversity of California, San Francisco
2 Previous Clinical Trials
583 Total Patients Enrolled
1 Trials studying Attention Deficit Hyperactivity Disorder (ADHD)
79 Patients Enrolled for Attention Deficit Hyperactivity Disorder (ADHD)
~15 spots leftby Dec 2025